Bhat Ganesh, Baba Chalamalasetty Sreenivasa, Pandey Amaresh, Kumari Neeraj, Choudhuri Gourdas
Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow.
Trop Gastroenterol. 2013 Jan-Mar;34(1):18-24. doi: 10.7869/tg.2012.86.
Insulin resistance has been recognized as a major factor in the development of non-alcoholic fatty liver disease (NAFLD). The association between insulin resistance and NAFLD, as a risk factor independent of obesity has been less well established. This study aims to determine presence of insulin resistance and components of metabolic syndrome in non-obese patients with NAFLD.
150 patients (mean age 42.25 _ 10.50 y; 115 (76%) male, 35 (24%) female) diagnosed with NAFLD participated in the study. We measured body mass index (BMI), waist circumference (WC), waist hip ratio (WHR), fasting lipid profile, fasting glucose, fasting insulin, and liver function. Insulin resistance was calculated using the homeostasis model of assessment (HOMA) formula. Insulin resistance was arbitrarily considered altered when it was >1.64.
120 (80%) of the 150 patients were pbese (BMI >23) according to the Asia Pacific criteria. 40 (30%) had metabolic syndrome. 97.5% (117/120) had insulin resistance with mean HOMA-insulin resistance (IR) of 10.9+/-5.3. Thirty (20%) were non-obese; of these, 7 had central obesity (WC > 90 cm for men, > 80 cm for women). Twenty-three (15.3%) patients were lean NAFLD with BMI 21.6+/-1.5, WC 82.9+/-4.7 (BMI< 23, WC <90 cm in men and < 80 cm in women) 80% of these 23 (18/23) had insulin resistance with mean HOMA-IR of 3.4+/-1.9. Only 4 (17%) did not have any component of metabolic syndrome.
Insulin resistance often associated with metabolic syndrome is common and plays a key role amongst lean Indian patients with non-alcoholic fatty liver disease.
胰岛素抵抗已被认为是非酒精性脂肪性肝病(NAFLD)发展的主要因素。胰岛素抵抗与NAFLD之间的关联,作为一个独立于肥胖的危险因素,尚未得到充分证实。本研究旨在确定非肥胖NAFLD患者中胰岛素抵抗和代谢综合征的组成成分。
150例被诊断为NAFLD的患者(平均年龄42.25±10.50岁;男性115例(76%),女性35例(24%))参与了本研究。我们测量了体重指数(BMI)、腰围(WC)、腰臀比(WHR)、空腹血脂、空腹血糖、空腹胰岛素和肝功能。使用稳态模型评估(HOMA)公式计算胰岛素抵抗。当胰岛素抵抗>1.64时,任意认为其发生改变。
根据亚太标准,150例患者中有120例(80%)肥胖(BMI>23)。40例(30%)患有代谢综合征。97.5%(117/120)有胰岛素抵抗,平均HOMA-胰岛素抵抗(IR)为10.9±5.3。30例(20%)为非肥胖;其中,7例有中心性肥胖(男性WC>90 cm,女性>80 cm)。23例(15.3%)患者为瘦型NAFLD,BMI为21.6±1.5,WC为82.9±4.7(男性BMI<23,WC<90 cm,女性<80 cm)。这23例患者中有80%(18/23)有胰岛素抵抗,平均HOMA-IR为3.4±1.9。只有4例(17%)没有任何代谢综合征的组成成分。
胰岛素抵抗常与代谢综合征相关,在瘦型印度非酒精性脂肪性肝病患者中很常见,且起关键作用。